跳至主要内容
临床试验/NCT03699891
NCT03699891已完成不适用

Evaluation of the Fortilink IBF System With TETRAfuse Technology

RTI Surgical5 个研究点 分布在 1 个国家目标入组 119 人开始时间: 2018年11月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
RTI Surgical
入组人数
119
试验地点
5
主要终点
Safety outcomes associated with use of the Fortlink System

研究概览

简要总结

This is a multi-center, post-market, retrospective study to collect safety and performance data for patients implanted with the Fortilink IBF System.

详细描述

This is a multi-center, post-market, retrospective study to collect safety and performance data for patients implanted with the Fortilink IBF System.

The study will include up to 110 patients at up to 8 US sites. All patients implanted with the Fortilink System at a site will be included in the data collection. The goal is to collect data for at least 100 subjects, but the sample size will be capped at 110 to ensure that all patients at a given site are included in the analysis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patient must have had an attempted implant of the Fortilink IBF System

排除标准

  • There are no exclusion criteria

结局指标

主要结局

Safety outcomes associated with use of the Fortlink System

时间窗: Up to 1 year

Safety assessment includes evaluation of all adverse events or complications related to the procedure and post-operative adverse events.

次要结局

未报告次要终点

研究者

发起方
RTI Surgical
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验

Evaluation of the Fortilink IBF System With... | 临床试验